Espace MD Brillance SRL
Espace MD Brillance reported total assets of 20,326 € at the end of the 2025 financial year (annual accounts filed with the NBB on 11 Jun 2026).
The score of Espace MD Brillance shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +19 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Espace MD Brillance's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 Jun 2026
- Year ended 31 Dec 2024filed on 11 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jun 2024
- Year ended 31 Dec 2022filed on 19 Jun 2023
- Year ended 31 Dec 2021filed on 17 Aug 2022
Espace MD Brillance's financial analysis
- Solvency-282.1%sector median: 61.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Espace MD Brillance
Espace MD Brillance's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0649.660.864
- VAT number
- BE0649660864
- Peppol
- Registered · 0208:0649660864 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Mar 2016
- Registered office
- 1370 Jodoigne
- Latest accounts
- 2025 · filed on 11 Jun 2026
- Activity
- Translation activities (NACE 74301)
Espace MD Brillance (SRL) has been based in Jodoigne since 2016, active in: translation activities. For 2025, it reports a net profit of 9,123 € and equity of −57,349 €; its revenue is not published. Its solvency stands at -282.1%, below the median of its sector (61.0%).
Companies similar to Espace MD Brillance
Companies in the same business, of comparable size and area, outside its group.
- MINT Translations Company Translation and interpretation activities Waterloo · balance sheet 10,078 €
- Write ON Target Business and other management consultancy activities Mouscron · balance sheet 18,114 €
- European Translation Network Translation and interpretation activities Beauvechain · balance sheet 22,458 €
- Advies- en Taalservice De Clercq Business and other management consultancy activities Oosterzele · balance sheet 25,695 €
- Marine KATZ Business and other management consultancy activities Namur · balance sheet 15,211 €
- Kataklop Translation and interpretation activities Heist-op-den-Berg · balance sheet 6,102 €
- Nitanco Business and other management consultancy activities Woluwe-Saint-Lambert · balance sheet 9,339 €
- Sanglier Management AND Consulting Business and other management consultancy activities Momignies · balance sheet 59,635 €
Frequently asked questions about Espace MD Brillance
What is the revenue of Espace MD Brillance?
Espace MD Brillance files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Espace MD Brillance?
In Belgium, the VAT number is the company number prefixed with BE: BE0649660864 for Espace MD Brillance, if the company is VAT-registered. Its company number (CBE) is 0649.660.864.
Where is the registered office of Espace MD Brillance?
According to the CBE register, the registered office of Espace MD Brillance is in 1370 Jodoigne.
What is the equity of Espace MD Brillance?
At the close of the 2025 financial year, the equity of Espace MD Brillance amounts to -57,349 €, a solvency of -282.1% of total assets.
Who manages Espace MD Brillance?
The register lists 1 active mandates at Espace MD Brillance. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Espace MD Brillance
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →